Calypso Capital Ii Designated Activity Company

Company Summary

Calypso Capital Ii Designated Activity Company was set up on Friday the 5th of July 2013. Their current partial address is Corrig Road Sandyford Business Park Dublin 18, and the company status is Dissolved with the company closing on Wednesday the 2nd of June 2021. The company's current directors have been the director of 382 other Irish companies between them; 156 of which are now closed. Calypso Capital Ii Designated Activity Company has 1 shareholder. This Irish company shares its Eircode with at least 609 other companies.

Company Vitals

  • Company Name:Calypso Capital Ii Designated Activity Company
  • Time in Business:7 Years
  • Company Number:529898
  • Current Status:Dissolved (02/06/2021)
  • May Trade As:Calypso Capital Ii DAC
  • Size:Large Company
  • Principal Activity:Security Broking and Fund Management
  • Partial Address:Corrig Road Sandyford Business Park Dublin 18

Documents

DocumentPagesEffectiveReceived
Form E6: Return of final winding up meeting122/12/202023/12/2020
Form E4: Liquidator`s Statement of Proceedings and Position of Winding Up522/12/202023/12/2020
Form G1 - Special Resolution to Wind up122/12/202023/12/2020
Form E5: Liquidator`s Final Statement of Accounts322/12/202023/12/2020
C6 MEMO OF SATISFACTION OF A CHARGE-FULL-08/01/201801/12/2020
E4 LIQUIDATOR PERIODIC STATEMENT OF ACCOUNT530/11/202030/11/2020
E3 LIQUIDATORS A/C OF HIS ACTS AND DEALINGS431/05/202008/07/2020
E4 LIQUIDATOR PERIODIC STATEMENT OF ACCOUNT531/05/202022/06/2020
E4 LIQUIDATOR PERIODIC STATEMENT OF ACCOUNT1030/11/201913/12/2019
E3 LIQUIDATORS A/C OF HIS ACTS AND DEALINGS831/05/201918/06/2019
E4 LIQUIDATOR PERIODIC STATEMENT OF ACCOUNT1031/05/201910/06/2019
E2 NOTICE OF APPOINTMENT OF LIQUIDATOR201/06/201805/07/2018
MEMBERS VOLUNTARY WINDING UP DEC OF SOLV829/05/201812/06/2018
B1 ANNUAL RETURN829/06/201729/06/2017
Constitution10217/08/201619/08/2016
A1 APPLICATION TO REGISTER AS A NEW COMPANY,1505/07/201301/07/2013

This company has 29 other documents.